首页
期刊导航
期刊检索
论文检索
新闻中心
期刊
期刊
论文
首页
>
《国际眼科杂志:英文版》
>
2018年11期
>
Comment on “Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration”
Comment on “Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration”
(整期优先)网络出版时间:2018-11-21
作者:
Dan Calugaru;Mihai Calugaru
医药卫生
>眼科
分享
打印
同系列资源
资料简介
/
1
同系列内容
《国际眼科杂志:英文版》2018年11期 - Comment on “Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration”
2018-11-21
423
《国际眼科杂志:英文版》2018年11期 - Primary sino-orbital peripheral T-cell lymphoma presenting as unilateral periorbital swelling: a case report
2018-11-21
357
《国际眼科杂志:英文版》2018年11期 - Serous macular detachment due to nasally located optic disc pit-coloboma
2018-11-21
2031
《国际眼科杂志:英文版》2018年11期 - X-linked juvenile retinoschisis: phenotypic and genetic characterization
2018-11-21
4990
《国际眼科杂志:英文版》2018年11期 - Posterior chamber phakic intraocular lens for the correction of high myopic anisometropic amblyopia in adults
2018-11-21
3937
查看全部
来源期刊
国际眼科杂志:英文版
2018年11期
相关推荐
Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
Fixed bimonthly aflibercept in nave and switched neovascular age-related macular degeneration patients:one year outcomes
Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis
Correlation of neutrophil/lymphocyte and platelet/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration
Matrix γ-carboxyglutamate protein and Fetuin-A, in wet type age-related macular degeneration
同分类资源
更多
[眼科]
Autologous sclera-muscle flaps technique in evisceration with hydroxyapatite implantation
[眼科]
准分子激光原位角膜磨镶术后早期眩光对暗视下对比敏感度的影响
[眼科]
糖尿病视网膜病变早期发病机制研究进展
[眼科]
20G标准三通道玻切治疗外伤性脉络膜上腔出血
[眼科]
羊膜移植后的临床病理报告1例
相关关键词
Comment on “Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration”
/
1
重新阅读
+在线打印
返回顶部